Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
In view of the multifactorial nature of Alzheimer’s disease (AD), multitarget small molecules (MTSM) represent the most potent and attractive therapeutic strategy to design new drugs for Alzheimer’s disease therapy. The new MTSM KojoTacrines (KTs) were designed and synthesized by juxtaposition of se...
Үндсэн зохиолчид: | , , , , , , , , , , , , , , |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Taylor & Francis Group
2019-01-01
|
Цуврал: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Нөхцлүүд: | |
Онлайн хандалт: | http://dx.doi.org/10.1080/14756366.2018.1538136 |